Skip to main content

Table 2 Comparison of two groups of Chechen CF patients

From: Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus

 

Group 1 (n = 17)

Group 2 (n = 8)

 

CFTR genotype

c.[1545_1546delTA];[1545_1546delTA] (p.[Tyr515X];[Tyr515X]); (1677delTA/1677delTA)

c.[1545_1546delTA];[274G > A] (p.[Tyr515X];[Glu92Lys]); (1677delTA/E92K)

p-value

Age at last clinical examination (yrs)

5.66 ± 8.28 (0.29÷31.46)

4.53 ± 4.13 (0.92÷11.92)

> 0.05

Age at diagnosis (yrs)

1.66 ± 0.91 (0.00÷20.18)

1.07 ± 0.91 (0.16÷3.00)

> 0.05

BMI (kg/m2)

14.93 ± 3.12 (12.30÷24.88)

15.92 ± 2.55 (13.00÷21.00)

> 0.05

Sweat chloride (mM/L)

120.25 ± 36.27 (100.00÷134.00)

120.25 ± 15.62 (100.00÷134.00)

> 0.05

FEV1 (% predicted)

82.66 ± 26.85 (52.00÷102.00)

91.50 ± 2.12 (90.00÷93.00)

> 0.05

FVC (% predicted)

93.66 ± 27.09 (68.00÷122.00)

91.50 ± 2.12 ((90.00÷93.00)

> 0.05

Meconium ileus

0

0

 

Liver cirrhosis

0

0

 

CF-related diabetes mellitus

0

0

 

Fecal elastase 1 concentration

≥200 μg/g

0

8

< 0.0001

< 200 μg/g

17

0

S. aureus lung colonization

44%

14%

> 0.05

P. aeruginosa lung colonization

69%

14%

0.024